
Sign up to save your podcasts
Or


The guys discuss the potential consequences of Pfizer finally acquiring AstraZeneca. After that they dive into earnings, a new report highlighting Apple's global iPhone recovery, and a reader email on the state of the SaaS industry.
By The Motley Fool4.7
16041,604 ratings
The guys discuss the potential consequences of Pfizer finally acquiring AstraZeneca. After that they dive into earnings, a new report highlighting Apple's global iPhone recovery, and a reader email on the state of the SaaS industry.

3,221 Listeners

1,487 Listeners

808 Listeners

948 Listeners

520 Listeners

1,168 Listeners

2,184 Listeners

825 Listeners

1,423 Listeners

1,039 Listeners

9,717 Listeners

195 Listeners

826 Listeners

85 Listeners

585 Listeners

1,039 Listeners

54 Listeners